Navigation Links
Newly approved oral medication slows rheumatoid arthritis joint damage
Date:1/23/2013

A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX). Results of the 12-month interim analysis of the efficacy of tofacitinib appear in Arthritis & Rheumatism, a journal published by Wiley on behalf of the American College of Rheumatology (ACR).

RA is a chronic, autoimmune disease that causes inflammation, pain and swelling of the joints. Over time, RA may destroy joints, impair daily function, and lead to significant disability. The World Health Organization (WHO) estimates that RA affects up to one percent of individuals worldwide and 1.3 million of those are Americans according to the ACR.

"Tofacitinib inhibits Janus kinase (JAK) enzymes that are found in white blood cells, and which help to regulate the immune system," explains lead investigator Dr. Dsire van der Heijde from Leiden University Medical Center in The Netherlands. "We are examining the oral JAK inhibitor, tofacitinib, as a disease-modifying anti-inflammatory drug (DMARD) and for its ability to modulate the immune system in those with RA."

In this 24-month, double-blind, placebo-controlled study, 797 participants were randomized (4:4:1:1) to receive 5 mg of tofacitinib twice daily (BID) (n=321); 10 mg of tofacitinib BID (n=316); placebo to tofacitinib 5 mg BID (n=81); or placebo to tofacitinib10 mg BID (N=79). Participants had a mean age of 53 years, 85% were female, 54% were non-Caucasian, and the mean duration of RA was 9 years. Patients who did not respond to placebo were advanced to tofacitinib at three months and the remaining placebo participants at six months.

Results from a planned 12-month interim analysis from the 24-month, Phase 3 trial show that tofacitinib is effective in preserving joint structure in patients with moderate to severe RA who had an inadequate response to MTX therapy. The dif
'/>"/>

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Neurological Wellness Center Pays Tribute to Newly Released Study Announcing TBI Treatment Breakthrough
2. Newly Updated 'Critical Bench' Teaches People How to Gain Muscle, Says Tony Nguyen
3. Newly Launched Blenderreviews101.com - The Best and Complete Resource for Blender Reviews
4. Newly Released “H Miracle” Can Teach People How to Cure Hemorrhoids, Says Health Review Center
5. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
6. The Newly Updated "The Diet Solution Program" Helps People Lose Body Fat, Says Health Review Center
7. Newly Released ProSkin 2.0 and ProMood Final Cut Pro X Plugins at Pixel Film Studios
8. Newly insured patients may have trouble finding primary care physicians
9. Moffitt Cancer Center melanoma expert reviews unique adverse events with newly approved drug
10. Study: 21 percent of newly admitted nursing home residents sustain a fall during their stay
11. Newly Aggressive Dogs May Be Reacting to Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 29, 2015 , ... "I ... from Miller Place, N.Y. "I specialize in manual therapy, and my invention will ... can be used for additional muscle dysfunction throughout the body." , They developed ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... Next weekend ... of summer (which astronomically, officially ends on September 22nd this year). For IT security ... security hangovers linger on which could prove far more costly than a simple headache. ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health ... and sell Arterosil and Arterosil HP, and that all claims and counterclaims have ... Health Sciences, LLC (VHS) in the United States District Court for the Southern ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of ... for the position they are applying for, they are unable to pass the initial ... considering altering drug testing policies in order to be able to hire long-term, skilled ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a non-invasive ... two years, the longest of any cellulite reduction system currently on the market. ... solution for their cellulite, according to Dr. Robert Weiss, director of the premier MD ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
... By Denise Mann HealthDay Reporter , WEDNESDAY, Dec. ... help us say "bon voyage" to the dreaded "cruise-ship" tummy ... off the norovirus that has sickened many cruisers in recent ... cramping, diarrhea and vomiting, and spreads easily from person to ...
... 2011 A dramatic increase in the incidence of ... bowel syndrome, has led to concern about how modern ... the context of a foresight study under the auspices ... scientists has examined the challenges associated with chronic inflammatory ...
... time, scientists have altered natural bioelectrical communication among cells ... be created at a particular location within a vertebrate ... (frog) embryos, biologists at Tufts University,s School of Arts ... eyes outside of the head area. The researchers ...
... Reporter , WEDNESDAY, Dec. 7 (HealthDay News) -- Women ... avoiding unnecessary medical radiation, forgoing menopausal hormone therapy and ... about using hair dyes or cellphones, a broad new ... on environmental factors that may affect breast cancer risk, ...
... The latest episode in the American Chemical Society,s ... discusses the discovery of bisphenol A (BPA) in 94 ... recycling of those receipts spreads BPA to paper napkins, ... the podcast, Kurunthachalam Kannan, Ph.D., explains that manufacturers produce ...
... too multifaceted to be left solely in the hands of ... latest Healthy People 2020 Objectives for the Nation. A ... a program that sets the national agenda for health promotion ... goals. Two papers published in the December ...
Cached Medicine News:Health News:Vaccine Might One Day Prevent 'Cruise Ship' Stomach Bug 2Health News:Vaccine Might One Day Prevent 'Cruise Ship' Stomach Bug 3Health News:Scientists identify strategies to conquer lifestyle and genetic factors related to chronic diseases 2Health News:Scientists identify strategies to conquer lifestyle and genetic factors related to chronic diseases 3Health News:Scientists identify strategies to conquer lifestyle and genetic factors related to chronic diseases 4Health News:Researchers discover that changes in bioelectric signals cause tadpoles to grow eyes in back, tail 2Health News:Researchers discover that changes in bioelectric signals cause tadpoles to grow eyes in back, tail 3Health News:Expert Panel Pinpoints Environmental Culprits in Breast Cancer 2Health News:Expert Panel Pinpoints Environmental Culprits in Breast Cancer 3Health News:Expert Panel Pinpoints Environmental Culprits in Breast Cancer 4Health News:Recycled thermal cash register receipts spread BPA to other paper products: ACS podcast 2Health News:Improving health will take a village 2
(Date:8/28/2015)... SAN FRANCISCO, Calif. , Aug. 28, 2015 /PRNewswire/ ... for the treatment of cancer, today announced the filing ... U.S. Securities and Exchange Commission (SEC) relating to a ... number of shares to be offered and the price ... CytomX intends to list its common stock under the ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Developed by Roche under the trade name of ... the world. In Feb.26, 2010, it was approved by ... available in China all come ...
(Date:8/28/2015)... , Aug. 28, 2015  Today, in final ... (CDC) Contact Lens Health Week, 1-800 Contacts is sharing ... found that contact lens wearers who do not properly ... risk for eye infections. Most contact ... lenses, but a clean lens case is sometimes overlooked.  ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Bevacizumab Market 2015-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2
... WESTON, Fla., Jan. 14, 2011 American Scientific ... (Pink Sheets: ASFX ) wishes to announces that ... is available at www.sec.gov , has been declared effective ... Registration Statement means that the Company will commence reporting of ...
... Research Institute (IDRI) today announced it has received a ... Foundation for "Chemical genomics for the identification of targets ... is to identify new leads and new drug targets ... of producing new drugs to treat tuberculosis (TB). The ...
Cached Medicine Technology:American Scientific Resources, Inc. Announces S-1 Registration Statement Effective; Commences Public Reporting Requirements 2IDRI Awarded Grant from Bill and Melinda Gates Foundation to Identify Candidates for Novel TB Drugs 2
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 130o....
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 110o. Most popular size or model....
25 gauge cannula. 2 mm vertical spatula tip with opening on right side. 10 mm from tip to bend. Polished finish....
Angled blade and flat serrated handle with polished finish. Blade: 1 mm x 10 mm....
Medicine Products: